about
sameAs
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityCustomizing monoclonal antibodies for the treatment of methamphetamine abuse: current and future applicationsTargeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood-brain barrier divide.Directed Evolution of Human Heavy Chain Variable Domain (VH) Using In Vivo Protein Fitness FilterNonsmall cell lung cancer therapy: insight into multitargeted small-molecule growth factor receptor inhibitorsIsolation of alpaca anti-hapten heavy chain single domain antibodies for development of sensitive immunoassayStructural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolitesThe Structural Basis of Antibody-Antigen RecognitionOptimal Neutralization of Centruroides noxius Venom Is Understood through a Structural Complex between Two Antibody Fragments and the Cn2 Toxin.Nanobodies as novel agents for cancer therapy.Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries.Production of a novel camel single-domain antibody specific for the type III mutant EGFR.Affinity maturation of Fab antibody fragments by fluorescent-activated cell sorting of yeast-displayed libraries.Intradiabodies, bispecific, tetravalent antibodies for the simultaneous functional knockout of two cell surface receptors.Preparation and functional studies of hydroxyethyl chitosan nanoparticles loaded with anti-human death receptor 5 single-chain antibody.A new generation of protein display scaffolds for molecular recognition.Ribosome display for improved biotherapeutic molecules.The use of immunoliposome for nutrient target regulation (a review).Creating protein affinity reagents by combining peptide ligands on synthetic DNA scaffolds.A modular IgG-scFv bispecific antibody topology.Rational conversion of affinity reagents into label-free sensors for Peptide motifs by designed allosteryNanoparticle targeting to diseased vasculature for imaging and therapy.Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.In vitro methods for peptide display and their applications.Discovery of hapten-specific scFv from a phage display library and applications for HER2-positive tumor imagingModification of the loops in the ligand-binding site turns avidin into a steroid-binding protein.Phage display approaches for the isolation of monoclonal antibodies against dengue virus envelope domain III from human and mouse derived libraries.Preparation of human scFv antibody against nasopharyngeal carcinoma and identification of its specificity.Targeted radioimmunotherapy: the role of ¹³¹I-chTNT-1/B mAb (Cotara) for treatment of high-grade gliomas.Human TNF cytokine neutralization with a vNAR from Heterodontus francisci shark: a potential therapeutic useMolecular structures of trimeric HIV-1 Env in complex with small antibody derivatives.Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samples.Quantification of protein interactions and solution transport using high-density GMR sensor arrays.Strategies to stabilize compact folding and minimize aggregation of antibody-based fragmentsSingle-domain antibodies and their utility.Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system.Development trends for generation of single-chain antibody fragments.Development and characterization of recombinant antibody fragments that recognize and neutralize in vitro Stx2 toxin from Shiga toxin-producing Escherichia coli.Vascular endothelial growth factor biology: clinical implications for ocular treatmentsAntibody-based sensors: principles, problems and potential for detection of pathogens and associated toxins
P2860
Q24546366-33DDDAA0-6EFF-4C58-882F-7A31F0CBEACDQ26864041-BA26C0B1-8774-4603-BDCF-41E51167F73DQ27010580-2F418BD2-E04C-42B3-85D6-429BDA4CB114Q27684059-49916A22-C599-4EAF-9AF3-54C8C8C63272Q27693185-8F46A84D-2F15-4924-8A0B-209F0B78A8DDQ28395939-5822F027-09A4-4F8A-BE7D-EC69A2BF54B6Q28536667-CE923AAA-338D-4708-BC7E-2F294AB0173CQ28972262-E7CF4276-2051-435B-A428-308074A6C80FQ30381626-E3D8B179-6E17-4D65-9CF8-927DD09FA45BQ30778309-F820D163-C93E-49A0-8D4E-D4BCCDFDA625Q31079441-F1CCB8FC-A1D0-431D-90CA-FC2BFB550771Q31138512-363B06A1-2DDA-4696-A158-A5E95862E40EQ31148151-1B5695F3-C935-45FE-9954-9D22AE2E5CCDQ31155271-903B16B5-518C-486B-A285-167A6671D88AQ31163344-2CF6166B-1202-481C-9997-BEE637AFB3EFQ33230194-E2F7ABC4-B673-4304-A23C-79D220184594Q33232465-205E5456-19BE-4948-990A-55EFDE1E6920Q33263078-D50EA77F-B90E-4BF8-ABC9-BA5FCF6BDC4BQ33515335-FB54C9B3-E23B-4D47-B0DB-732D3D326878Q33519465-49D26E0B-D712-4D9C-A0AC-4986617F7B83Q33742154-B1C9C4D4-0385-4D7A-80E0-C9B02EFD2E80Q33831738-3E3D50BA-FBA6-49A3-AC54-73900F79989EQ33852396-C34A3458-9FF8-4D9C-8191-921E630C8273Q33917861-0A309927-FA3A-4BAA-9EBE-DFD8AF6E41F1Q33921086-F5925C75-F82F-48FF-9F13-F9E1D6E352CCQ33928111-6B806273-9B0A-4A7D-8503-2CF69263B29EQ34226542-B440DC03-FA14-44AB-863A-06AF93336A08Q34230754-098EF266-99EC-4365-8DC3-9E100781F347Q34286194-8A4387DC-8E26-4102-90E8-5B909321FD64Q34503960-3FC594B8-7DE8-4B78-98D5-2D11B23EA48EQ34522657-B4A2426B-7D66-49F7-868C-DA9800F69E30Q34566355-63C14968-F1AF-405B-AAC1-EE49EA5C260CQ34949507-AC3F613C-323E-480A-B549-D2D46A61438CQ35018813-1968C8E3-894A-414A-9A11-B82CC85A4229Q35089545-A0ED6F45-6D75-484C-B611-3B16190650E0Q35163455-FAFAEB57-A74C-40A3-9E2B-3F8BE32150CCQ35216785-DC3C175A-6520-411D-A607-E8642F72F566Q35581606-D97F18A8-EB7B-469F-86AB-BBD9A2B97884Q35762769-FFB72BEE-1D2C-4C17-BB68-B4B00A9347E1Q35795550-D0C81570-11E4-423C-8387-1A6D96EA6B53
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Engineered antibodies
@ast
Engineered antibodies
@en
Engineered antibodies
@nl
type
label
Engineered antibodies
@ast
Engineered antibodies
@en
Engineered antibodies
@nl
prefLabel
Engineered antibodies
@ast
Engineered antibodies
@en
Engineered antibodies
@nl
P2860
P356
P1433
P1476
Engineered antibodies
@en
P2093
Christelle Souriau
Peter J Hudson
P2860
P2888
P304
P356
10.1038/NM0103-129
P407
P577
2003-01-01T00:00:00Z